5 High Growth Stocks to Buy and Hold for the Next Decade

3. American Healthcare REIT, Inc. (NYSE:AHR)

On May 22, 2026, BofA raised the firm’s price target on American Healthcare REIT, Inc. (NYSE:AHR) to $67 from $63 and maintained a Buy rating on the shares. BofA said it updated price targets on several REITs after reviewing its models.

On May 20, 2026, American Healthcare REIT, Inc. (NYSE:AHR) announced an underwritten public offering of 14M shares of common stock. The 14M-share spot secondary offering was priced at $50.40, below the prior closing price of $51.68. BofA Securities is acting as the underwriter for the offering.

Earlier in May, American Healthcare REIT, Inc. (NYSE:AHR) reported Q1 normalized FFO of 50c, ahead of the consensus estimate of 47c. Revenue totaled $650.77M, below the consensus estimate of $687.04M. CEO Jeff Hanson said the quarter reflected an “exceptionally strong period” across core metrics, including the company’s ninth consecutive quarter of double-digit Same-Store NOI growth, efficient capital formation and deployment, a strengthened balance sheet, and a raise to full-year 2026 Same-Store NOI growth and NFFO per share guidance.

American Healthcare REIT, Inc. (NYSE:AHR) owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man.

1281292 - 11759070 - 1